Roivant Sciences Ltd.
ROIV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001635088
In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 7 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Q2 2022 vs. Q1 2022
How the institutions holding Roivant Sciences Ltd. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 52 | 71 | +19 |
| Shares | 349.2M | 360.5M | +11.3M (+3.2%) |
| Value | $1.72B | $1.47B | −$257.7M (−14.9%) |
New holders (30)
Institutions that held Roivant Sciences Ltd. at the end of Q2 2022 but not at the end of Q1 2022.
Sold out (11)
Institutions that held Roivant Sciences Ltd. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Millennium Management LLC | 140,186 | $693.0K |
| Occudo Quantitative Strategies LP | 64,858 | $320.0K |
| Two Sigma Investments, LP | 50,158 | $248.0K |
| Jane Street Group, LLC | 49,897 | $246.0K |
| Schonfeld Strategic Advisors LLC | 43,500 | $215.0K |
| Jump Financial, LLC | 41,243 | $203.0K |
| InterOcean Capital Group, LLC | 15,000 | $74.0K |
| Royal Bank of Canada | 6,065 | $30.0K |
| Paloma Partners Management Co | 4,281 | $21.0K |
| Prospera Financial Services Inc | 4,276 | $21.0K |
| Wolverine Asset Management LLC | 100 | $0 |